On the other hand, immunosuppressive responses including M2 macrophage infiltration and IL-10 secretion were alleviated, demonstrating that the hydrogel-based continuous release of DOX and R837 can provide an effective cancer treatment strategy. This evidence concerns the gene IL10 and cancer.